Prescription Required(Save Upto 85%)
Nivolumab is indicated to treat unresectable or metastatic melanoma, melanoma as adjuvant treatment, resectable or metastatic non-small cell lung cancer, small cell lung cancer, advanced renal cell carcinoma, classical Hodgkin lymphoma, squamous cell carcinoma of the head and neck, urothelial carcinoma, microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer, hepatocellular carcinoma, and esophageal cancer.
Nivolumab is also approved for the treatment of HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal adenocarcinoma when used in combination with a fluoropyrimidine- and platinum-containing chemotherapy regimen.
Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time.
Before taking it, tell your doctor if have lung disease, liver, or kidney problems or are taking any medicines to treat infections.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using
Opdyta 100mg Injection is an anti-cancer medication. It works by blocking a protein (PD-1) on the surface of certain immune cells called T-cells. This action activates the T-cells to locate and kill cancer cells.
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Ans : Some patients receiving Opdyta 40mg Injection may experience skin reactions such as rash, itching, or blistering. These side effects should be reported to a healthcare provider as they may require treatment.
Ans : There is limited data on the long-term effects of Opdyta 100mg Injection on fertility. However, the medication may impact fertility in some patients, particularly those receiving high doses or long-term treatment. Patients concerned about their fertility should discuss their options with a healthcare provider.
Ans :Opdyta 100mg Injection may cause changes in blood sugar levels, leading to diabetes in some patients. Patients should be monitored closely for changes in their blood sugar levels during treatment.
Ans : Opdyta 100mg Injection is not currently approved for use in children. However, some clinical trials are underway to evaluate the safety and effectiveness of the medication in pediatric patients.
Ans :Opdyta 100mg Injection is one of several immunotherapy medications that are used to treat cancer. The specific medication used may depend on several factors, including the type and stage of the cancer being treated and the patient's response to treatment. Patients should discuss their options with a healthcare provider to determine the best treatment plan for their situation.
Ans :Opdyta 100mg Injection is an immunotherapy that enhances the body's natural immune response to cancer cells. Chemotherapy, on the other hand, works by killing cancer cells directly. While both treatments may be used in combination for some types of cancer, they work in different ways and may have different side effects.
Ans :Patients receiving Opdyta 100mg Injection treatment will typically be monitored closely for any signs of adverse reactions or changes in their cancer status. This may include regular blood tests, imaging studies, and physical exams.
